Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer

被引:9
|
作者
Saleh, Ali Jason [1 ]
Soltani, Bahram M. [1 ]
Dokanehiifard, Sadat [1 ]
Medlej, Abdallah [1 ]
Tavalaei, Mahmoud [2 ]
Mowla, Seyed Javad [1 ]
机构
[1] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[2] Bagiatallah Univ Med Sci, Tehran, Iran
关键词
PI3K signaling; PIK3CA-miR1; Colorectal cancer; Oncogene; APPL1; TrkC; PHOSPHATIDYLINOSITOL; 3-KINASE; TARGET PREDICTION; TUMOR-SUPPRESSOR; MIRNA PROMOTERS; CELL-LINES; IDENTIFICATION; APPL1; TRANSCRIPTION; BIOGENESIS; PROTEIN;
D O I
10.1007/s13277-016-5264-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PI3K/AKT signaling is involved in cell survival, proliferation, and migration. In this pathway, PI3K alpha enzyme is composed of a regulatory protein encoded by p85 gene and a catalytic protein encoded by PIK3CA gene. Human PIK3CA locus is amplified in several cancers including lung and colorectal cancer (CRC). Therefore, microRNAs (miRNAs) that are encoded within the PIK3CA gene might have a role in cancer development. Here, we report a novel microRNA named PIK3CA-miR1 (EBI accession no. LN626315), which is located within PIK3CA gene. A DNA segment corresponding to PIK3CA-premir1 sequence was transfected in human cell lines that resulted in generation of mature exogenous PIK3CA-miR1. Following the overexpression of PIK3CA-miR1, its predicted target genes (APPL1 and TrkC) were significantly downregulated in the CRC-originated HCT116 and SW480 cell lines, detected by qRT-PCR. Then, dual luciferase assay supported the interaction of PIK3CA-miR1 with APPL1 and TrkC transcripts. Endogenous PIK3CA-miR1 expression was also detected in several cell lines (highly in HCT116 and SW480) and highly in CRC specimens. Consistently, overexpression of PIK3CA-premir1 in HCT116 and SW480 cells resulted in significant reduction of the sub-G1 cell distribution and apoptotic cell rate, as detected by flowcytometry, and resulted in increased cell proliferation, as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. PIK3CA-miR1 overexpression also resulted in Wnt signaling upregulation detected by Top/Fop assay. Overall, accumulative evidences indicated the presence of a bona fide novel onco-miRNA encoded within the PIK3CA oncogene, which is highly expressed in colorectal cancer and has a survival effect in CRC-originated cells.
引用
收藏
页码:14089 / 14101
页数:13
相关论文
共 50 条
  • [31] Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
    Xing, Jeffrey C.
    Tufano, Ralph P.
    Murugan, Avaniyapuram Kannan
    Liu, Dingxie
    Wand, Gary
    Ladenson, Paul W.
    Xing, Mingzhao
    Trink, Barry
    PLOS ONE, 2012, 7 (11):
  • [32] Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer
    Liu, Shuying
    Li, Shunqiang
    Wang, Bailiang
    Liu, Wenbin
    Gagea, Mihai
    Chen, Huiqin
    Sohn, Joohyuk
    Parinyanitikul, Napa
    Primeau, Tina
    Do, Kim-Anh
    Vande Woude, George F.
    Mendelsohn, John
    Ueno, Naoto T.
    Mills, Gordon B.
    Tripathy, Debu
    Gonzalez-Angulo, Ana M.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 399 - 412
  • [33] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Zhu, Yu-Fen
    Yu, Bao-Hua
    Li, Da-Li
    Ke, Hong-Lin
    Guo, Xian-Zhi
    Xiao, Xiu-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (28) : 3745 - 3751
  • [34] Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
    Dirican, Ebubekir
    Akkiprik, Mustafa
    Ozer, Ayse
    TUMOR BIOLOGY, 2016, 37 (06) : 7033 - 7045
  • [35] Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
    Yasin, Faiza
    Sokol, Ethan
    Vasan, Neil
    Pavlick, Dean C.
    Huang, Richard S. P.
    Pelletier, Maureen
    Levy, Mia Alyce
    Pusztai, Lajos
    Lacy, Jill
    Zhang, Janie Yue
    Ross, Jeffrey S.
    Cecchini, Michael
    ONCOLOGIST, 2024, 29 (12) : 1059 - 1067
  • [36] Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
    Li, Weihua
    Qiu, Tian
    Dong, Lin
    Zhang, Fanshuang
    Guo, Lei
    Ying, Jianming
    JOURNAL OF CANCER, 2020, 11 (13): : 3827 - 3833
  • [37] Biochip detection of KRAS, BRAF, and PIK3CA somatic mutations in colorectal cancer patients
    Emelyanova, M. A.
    Amossenko, F. A.
    Semyanikhina, A. V.
    Aliev, V. A.
    Barsukov, Yu. A.
    Lyubchenko, L. N.
    Nasedkina, T. V.
    MOLECULAR BIOLOGY, 2015, 49 (04) : 550 - 559
  • [38] Biochip detection of KRAS, BRAF, and PIK3CA somatic mutations in colorectal cancer patients
    M. A. Emelyanova
    F. A. Amossenko
    A. V. Semyanikhina
    V. A. Aliev
    Yu. A. Barsukov
    L. N. Lyubchenko
    T. V. Nasedkina
    Molecular Biology, 2015, 49 : 550 - 559
  • [40] Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene mutations in Ugandan patients with colorectal cancer
    Wismayer, Richard
    Matthews, Rosie
    Whalley, Celina
    Kiwanuka, Julius
    Kakembo, Fredrick Elishama
    Thorn, Steve
    Wabinga, Henry
    Odida, Michael
    Tomlinson, Ian
    BMC CANCER, 2024, 24 (01)